Because HDAC inhibitors are known to preferentially induce caspase-8 activation to contribute to tumor cell death [10], we asked whether panobinostat induces caspase-8-dependent Sp1 protein degradation in MM cells. The gene discussed is HDAC9; the disease is Miyoshi myopathy.